These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 25524609)

  • 21. [Real-time PCR array for simultaneous detection of 37 kinds of fusion genes in leukemia].
    Liu HX; Zhu P; Zhang Y; Wang HX; DU JW; Liu J; Gu JY; Ou Y
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(8):526-32. PubMed ID: 17459201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a novel and myeloid specific role of the leukemia-associated fusion protein DEK-NUP214 leading to increased protein synthesis.
    Ageberg M; Drott K; Olofsson T; Gullberg U; Lindmark A
    Genes Chromosomes Cancer; 2008 Apr; 47(4):276-87. PubMed ID: 18181180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of translocation-associated fusion genes of FGFRI, MYC, NPMI, and DEK, but absence of the translocations in acute myeloid leukemia. A microarray analysis.
    Larramendy ML; Niini T; Elonen E; Nagy B; Ollila J; Vihinen M; Knuutila S
    Haematologica; 2002 Jun; 87(6):569-77. PubMed ID: 12031912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caspase-dependent apoptosis induction by targeted expression of DEK in Drosophila involves histone acetylation inhibition.
    Lee KS; Kim DW; Kim JY; Choo JK; Yu K; Seo SB
    J Cell Biochem; 2008 Mar; 103(4):1283-93. PubMed ID: 17685435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular biology of leukemia and lymphoma.
    Look AT; Downing JR
    Rev Invest Clin; 1994 Apr; Suppl():124-34. PubMed ID: 7886296
    [No Abstract]   [Full Text] [Related]  

  • 26. Progress in studies on the DEK protein and its involvement in cellular apoptosis.
    Hua Y; Hu H; Peng X
    Sci China C Life Sci; 2009 Jul; 52(7):637-42. PubMed ID: 19641868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective induction of leukemia-associated fusion genes by high-dose ionizing radiation.
    Deininger MW; Bose S; Gora-Tybor J; Yan XH; Goldman JM; Melo JV
    Cancer Res; 1998 Feb; 58(3):421-5. PubMed ID: 9458083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations of the AML1 transcription factor in human leukemia.
    Downing JR; Higuchi M; Lenny N; Yeoh AE
    Semin Cell Dev Biol; 2000 Oct; 11(5):347-60. PubMed ID: 11105899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DEK-CAN molecular monitoring of myeloid malignancies could aid therapeutic stratification.
    Garçon L; Libura M; Delabesse E; Valensi F; Asnafi V; Berger C; Schmitt C; Leblanc T; Buzyn A; Macintyre E
    Leukemia; 2005 Aug; 19(8):1338-44. PubMed ID: 15973457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene regulation in normal and leukaemic progenitor/stem cells.
    De Maria R; Grignani F; Testa U; Valtieri M; Ziegler BL; Peschle C
    Haematologica; 1999 Jun; 84 Suppl EHA-4():8-10. PubMed ID: 10907455
    [No Abstract]   [Full Text] [Related]  

  • 31. A distinct epigenetic signature at targets of a leukemia protein.
    Rossetti S; Hoogeveen AT; Liang P; Stanciu C; van der Spek P; Sacchi N
    BMC Genomics; 2007 Feb; 8():38. PubMed ID: 17266773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minireview: DEK and gene regulation, oncogenesis and AIDS.
    Sitwala KV; Mor-Vaknin N; Markovitz DM
    Anticancer Res; 2003; 23(3A):2155-8. PubMed ID: 12894590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent chromosomal translocations and fusion genes in leukemia-lymphoma cell lines.
    Drexler HG; MacLeod RA; Borkhardt A; Janssen JW
    Leukemia; 1995 Mar; 9(3):480-500. PubMed ID: 7885046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developmental impact of leukemic fusion genes on stem cell fate.
    Enver T; Tsuzuki S; Brown J; Hong D; Gupta R; Ford T; Egucchi MI; Egucchi M; Greaves M
    Ann N Y Acad Sci; 2005 Jun; 1044():16-23. PubMed ID: 15958693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impairment of erythroid and megakaryocytic differentiation by a leukemia-associated and t(9;9)-derived fusion gene product, SET/TAF-Ibeta-CAN/Nup214.
    Saito S; Nouno K; Shimizu R; Yamamoto M; Nagata K
    J Cell Physiol; 2008 Feb; 214(2):322-33. PubMed ID: 17620317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of cell cycle by graded expression of MLL-AF4 fusion oncoprotein.
    Caslini C; Serna A; Rossi V; Introna M; Biondi A
    Leukemia; 2004 Jun; 18(6):1064-71. PubMed ID: 14990976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein.
    Fazi F; Racanicchi S; Zardo G; Starnes LM; Mancini M; Travaglini L; Diverio D; Ammatuna E; Cimino G; Lo-Coco F; Grignani F; Nervi C
    Cancer Cell; 2007 Nov; 12(5):457-66. PubMed ID: 17996649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukemia-associated fusion proteins, dek-can and bcr-abl, represent immunogenic HLA-DR-restricted epitopes recognized by fusion peptide-specific CD4+ T lymphocytes.
    Makita M; Azuma T; Hamaguchi H; Niiya H; Kojima K; Fujita S; Tanimoto M; Harada M; Yasukawa M
    Leukemia; 2002 Dec; 16(12):2400-7. PubMed ID: 12454745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and isotopic labeling of structural domains of the human protein DEK.
    Devany M; Kotharu NP; Matsuo H
    Protein Expr Purif; 2005 Apr; 40(2):244-7. PubMed ID: 15766865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mixed lineage leukemia: roles in human malignancies and potential therapy.
    Marschalek R
    FEBS J; 2010 Apr; 277(8):1822-31. PubMed ID: 20236311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.